Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $111.75
-
Support level$109.83
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)49.1
- With a 62.8 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$66.69 | $117.41 | 91.3% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$99.03 | $106.80 | $109.81 | $109.20 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.0%
-
In the next month14.1%
-
In the next year52.1%
Period | Value |
---|---|
Historical (5 year) | 23.5% |
Last month | 29.5% |
Current estimate | 25.8% |
Next month forecast | 24.9% |